We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Proteros Biostructures GmbH and BioSolveIT GmbH Win Federal Funding for € 5.5 Million Fragment-Screening Project
News

Proteros Biostructures GmbH and BioSolveIT GmbH Win Federal Funding for € 5.5 Million Fragment-Screening Project

Proteros Biostructures GmbH and BioSolveIT GmbH Win Federal Funding for € 5.5 Million Fragment-Screening Project
News

Proteros Biostructures GmbH and BioSolveIT GmbH Win Federal Funding for € 5.5 Million Fragment-Screening Project

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Proteros Biostructures GmbH and BioSolveIT GmbH Win Federal Funding for € 5.5 Million Fragment-Screening Project"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioSolveIT GmbH and Proteros biostructures GmbH has announced that they have been awarded a three-year development grant from the German Federal Ministry of Education and Research (BMBF), through its BioChance programme. With the FragScreen project, the German ministry supports the development of fragment-based screening technologies.

The objective of this project is to develop and validate an integrated experimental and computational approach to determine binding of low-molecular weight compounds and molecular probes.

Both companies will work in partnership with the world-renowned research group of Prof. Dr. Gerhard Klebe at the University of Marburg. The consortium is completed by two Top25 global pharmaceutical companies which will contribute to the project from the perspective of the industry requirements.

The award highlights the German government’s recognition of the need to build joint development teams between leading academic institutions and industrial partners small and large to bridge the gap between the research lab and the marketplace, stimulating prosperity through innovation.

Advertisement